Moderna (MRNA) Asset Utilization Ratio (2019 - 2026)

Moderna (MRNA) has 8 years of Asset Utilization Ratio data on file, last reported at 0.19 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 21.09% year-over-year to 0.19 in Q1 2026; TTM through Mar 2026 was 0.19, a 21.09% decrease from a year earlier, with the FY2025 full-year figure at 0.15, down 26.11% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.19, up from 0.16 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for MRNA reached as high as 0.86 in Q1 2022 and fell as low as 0.16 in Q4 2025.
• Historically, Asset Utilization Ratio has averaged 0.43 across 5 years, with a median of 0.32 in 2024.
• Across the five-year window, Asset Utilization Ratio soared 216.97% in 2022 and slumped 51.35% in 2024, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.74 in 2022, then plunged by 51.27% to 0.36 in 2023, then sank by 40.23% to 0.22 in 2024, then slipped by 26.49% to 0.16 in 2025, then grew by 17.56% to 0.19 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.19 in Q1 2026, 0.16 in Q4 2025, and 0.18 in Q3 2025.